Pharmlog Pharma Logistik
Pharmlog Pharma Logistik, commonly referred to as Pharmlog, is a leading logistics provider in the pharmaceutical industry, headquartered in Germany. Established in 2003, the company has rapidly expanded its operations across Europe, specialising in temperature-controlled logistics and supply chain solutions tailored for the healthcare sector. Pharmlog offers a range of core services, including warehousing, distribution, and regulatory compliance, ensuring the safe and efficient delivery of pharmaceutical products. Their commitment to quality and innovation has positioned them as a trusted partner for numerous pharmaceutical companies. With a focus on maintaining the integrity of sensitive products, Pharmlog has achieved significant milestones, reinforcing its reputation as a key player in the pharmaceutical logistics market.
DitchCarbon Score
How does Pharmlog Pharma Logistik's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmlog Pharma Logistik's score of 36 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmlog Pharma Logistik's reported carbon emissions
In 2022, Pharmlog Pharma Logistik GmbH reported total greenhouse gas emissions of approximately 6,692,000 kg CO2e. This figure includes Scope 1 emissions of about 1,425,000,000 kg CO2e, Scope 2 emissions of approximately 242,000,000 kg CO2e, and significant Scope 3 emissions totalling around 6,616,000,000 kg CO2e. The company has set ambitious targets to reduce its greenhouse gas emissions by 46% for both Scope 1 and Scope 2 by 2030, using 2019 as the base year. This commitment aligns with the Science Based Targets initiative (SBTi) and reflects a proactive approach to climate action. Pharmlog's emissions data shows a slight increase from 2021, when total emissions were about 6,525,000 kg CO2e, with Scope 1 at approximately 1,522,000,000 kg CO2e and Scope 2 at around 321,000,000 kg CO2e. The company is actively working to measure and reduce its Scope 3 emissions, which are the largest contributor to its overall carbon footprint. As a current subsidiary of Viatris Inc., Pharmlog's climate commitments and emissions data are part of a broader corporate responsibility strategy. The company is classified as a small or medium enterprise (SME) and is committed to achieving reductions consistent with keeping global warming to 1.5°C.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 332,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 304,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 348,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmlog Pharma Logistik is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
